-transparent.png){kind=logo}
Neuroendocrine strategies in affective disorders have explored both resting values of hormones and hormonal responses to stimuli such as hypoglycemia, TRH, LHRH, dexamethasone, methadone and morphine. The abnormalities established to date have involved growth hormone, cortisol and TSH responses in particular. Prolactin has not been investigated to the same extent. We therefore describe several prolactin studies exemplifying selected neuroendocrine strategies. Our studies of prolactin responses included acute cases of either primary or secondary depression, stabilized bipolar patients, and healthy controls both off and on lithium. We found prolactin response to hypoglycemia significantly reduced in primary but not secondary depressions. Lithium administration led to flattened prolactin responses to hypoglycemia in stabilized bipolar patients but not in healthy controls. The flattened response in patients was observed already after 3 weeks of lithium, and remained flattened after years of treatment. The findings suggest a greater degree of prolactin response reduction in those patients showing most pronounced stability on lithium treatment.
E Grof, and
G M Brown, and
P Grof
January 1992,
Clinical neuropharmacology,
E Grof, and
G M Brown, and
P Grof
January 1982,
L'Encephale,
E Grof, and
G M Brown, and
P Grof
August 1987,
Archives of psychiatric nursing,
E Grof, and
G M Brown, and
P Grof
October 1974,
Psychopharmacology bulletin,
E Grof, and
G M Brown, and
P Grof
June 1986,
The Psychiatric clinics of North America,
E Grof, and
G M Brown, and
P Grof
January 2002,
Psychopharmacology bulletin,
E Grof, and
G M Brown, and
P Grof
January 1982,
Progress in neuro-psychopharmacology & biological psychiatry,
E Grof, and
G M Brown, and
P Grof
July 1981,
Journal of clinical psychopharmacology,
E Grof, and
G M Brown, and
P Grof
July 1981,
Psychopharmacology bulletin,
E Grof, and
G M Brown, and
P Grof
January 1987,
Advances in biochemical psychopharmacology,
